Bombesin stimulates invasion and migration of Isreco1 colon carcinoma cells in a Rho-dependent manner.

The membrane receptor for the neuropeptide bombesin/gastrin-releasing peptide (GRP) is expressed by a large fraction of human colorectal carcinoma cells. We reported previously a stimulation of cell adhesion and lamellipodia formation by the neuropeptide bombesin in the human, bombesin/GRP receptor-expressing, Isreco1 colorectal cancer cell line (J. C. Saurin et al., Cancer Res., 59: 962-967, 1999). Using invasion and motility assays, we demonstrate in this report that bombesin can both enhance the invasive capacity of Isreco1 cells in a dose-dependent manner (maximal effect at 1 nM) and stimulate the closure of wounds performed on confluent Isreco1 cells. These effects were reversed fully by the specific bombesin/GRP receptor antagonist D-Phe(6)-Bn(6-13)OMe used at 1 micro M. MMP-9 and urokinase-type plasminogen activator were expressed by Isreco1 cells, and bombesin did not significantly alter their level of secretion. Interestingly, exoenzyme C3 (10 micro g/ml) decreased cell invasiveness induced by bombesin by 70% and completely inhibited the migration of Isreco1 cells. Similarly, the Rho-kinase inhibitor Y-27632 dose-dependently reduced the effect of bombesin on cell invasion. Moreover, pull-down assays for GTP-bound RhoA demonstrated that bombesin was able to activate the small G-protein in Isreco1 cells. These results show that the neuropeptide bombesin is able to modulate invasiveness of Isreco1 colorectal carcinoma cells in vitro through a Rho-dependent pathway, leading to an increase in cell locomotion without a significant effect on tumor-cell associated proteolytic activity. These findings indicate that bombesin/GRP receptor expression may contribute to the cellular events that are critical for invasion/migration of colorectal carcinoma cells.

[1]  R. Benya,et al.  The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer , 2001, Peptides.

[2]  L. Van Aelst,et al.  Rho GTPases: signaling, migration, and invasion. , 2000, Experimental cell research.

[3]  A. Hall,et al.  Rho GTPases and their effector proteins. , 2000, The Biochemical journal.

[4]  S. Narumiya,et al.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. , 2000, Molecular pharmacology.

[5]  B. Zetter,et al.  Motility and invasion are differentially modulated by Rho family GTPases , 2000, Oncogene.

[6]  A. Mercurio,et al.  Rhoa Function in Lamellae Formation and Migration Is Regulated by the α6β4 Integrin and Camp Metabolism , 2000, The Journal of cell biology.

[7]  P. Andreasen,et al.  The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.

[8]  J C Reubi,et al.  Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. , 1999, The American journal of pathology.

[9]  P. Ducrotte,et al.  Postoperative management of stage II/III colon cancer: a decision analysis. , 1999, Gastroenterology.

[10]  A. Hall,et al.  Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction. , 1999, Molecular biology of the cell.

[11]  R. Benya,et al.  Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[12]  J C Reubi,et al.  Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. , 1999, Cancer research.

[13]  J. Cuber,et al.  Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isreco1 cell line. , 1999, Cancer research.

[14]  W. Kiosses,et al.  Regulation of the small GTP‐binding protein Rho by cell adhesion and the cytoskeleton , 1999, The EMBO journal.

[15]  Shuh Narumiya,et al.  An essential part for Rho–associated kinase in the transcellular invasion of tumor cells , 1999, Nature Medicine.

[16]  Natalie A. Lissy,et al.  Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration , 1998, Nature Medicine.

[17]  T. Thompson,et al.  Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines. , 1998, Cancer research.

[18]  M. Bologna,et al.  Plasminogen activator system modulates invasivecapacity and proliferation in prostatic tumor cells , 1998, Clinical & Experimental Metastasis.

[19]  F. Matsumura,et al.  Small GTP-binding Protein Rho Stimulates the Actomyosin System, Leading to Invasion of Tumor Cells* , 1998, The Journal of Biological Chemistry.

[20]  A. Albini,et al.  In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin , 1998, International journal of cancer.

[21]  R. Benya,et al.  Location and Characterization of the Human GRP Receptor Expressed by Gastrointestinal Epithelial Cells , 1997, Peptides.

[22]  L. Peso,et al.  Rho proteins induce metastatic properties in vivo , 1997, Oncogene.

[23]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[24]  S. Chevalier,et al.  Bombesin stimulates the motility of human prostate‐carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin‐associated proteins , 1997, International journal of cancer.

[25]  B. Sordat,et al.  Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. , 1997, Cancer research.

[26]  G. Johnson,et al.  Gα12 and Gα13 Stimulate Rho-dependent Stress Fiber Formation and Focal Adhesion Assembly (*) , 1995, The Journal of Biological Chemistry.

[27]  J. Primrose,et al.  High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa. , 1995, British Journal of Cancer.

[28]  G. Dockray,et al.  Gut Peptides: Biochemistry and Physiology , 1994 .

[29]  G. Schultz,et al.  Gq and G11 are concurrently activated by bombesin and vasopressin in Swiss 3T3 cells , 1994, FEBS letters.

[30]  J. Primrose,et al.  High affinity binding sites for gastrin releasing peptide on human gastric cancer and Ménétrier's mucosa. , 1993, Cancer research.

[31]  Anne J. Ridley,et al.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors , 1992, Cell.

[32]  H. Iishi,et al.  Enhancement by bombesin of colon carcinogenesis and metastasis induced by azoxymethane in wistar rats , 1992, International journal of cancer.

[33]  H. Iishi,et al.  Attenuating effect of ornithine decarboxylase inhibitor (1,3‐diaminopropane) on bombesin enhancement of gastric carcinogenesis induced by N‐methyl‐N'‐nitro‐N‐ nitrosoguanidine , 1992, International journal of cancer.

[34]  E. Gherardi,et al.  Regulation of cell movement: the motogenic cytokines. , 1991, Biochimica et biophysica acta.

[35]  W. T. Chen,et al.  Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. , 1989, The Journal of experimental zoology.

[36]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[37]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[38]  E. Dowdle,et al.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.

[39]  Suraiya Rasheed,et al.  Characterization of a newly derived human sarcoma cell line (HT‐1080) , 1974, Cancer.

[40]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.

[41]  J. Saurin,et al.  High gastrin releasing peptide receptor mRNA level is related to tumour dedifferentiation and lymphatic vessel invasion in human colon cancer. , 1999, European journal of cancer.

[42]  S. White,et al.  Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin. , 1999, Experimental lung research.

[43]  E. Rozengurt.  G Protein-Coupled Receptors in Gastrointestinal Physiology V. Gastrointestinal peptide signaling through tyrosine phosphorylation of focal adhesion proteins * , 1998 .

[44]  E. Rozengurt.  V. Gastrointestinal peptide signaling through tyrosine phosphorylation of focal adhesion proteins. , 1998, The American journal of physiology.

[45]  R. Jensen,et al.  Progress in the development of potent bombesin receptor antagonists. , 1991, Trends in pharmacological sciences.

[46]  John D. Minna,et al.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.

[47]  J. Minna,et al.  Autocrine growth factors in human small cell lung cancer. , 1985, Cancer surveys.

[48]  C. Pert,et al.  Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. , 1985, Clinical immunology and immunopathology.